Biomarker analysis to predict the pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer: An exploratory biomarker study of COMPASS, a randomized phase II trial

Background: The findings of COMPASS, a randomized phase II study, suggested that the regimens and courses of neoadjuvant chemotherapy (NAC) for locally advanced gastric cancer (GC) did not affect the pathological response. However, pathological complete response was achieved in 10% patients who rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshima, Takashi, Yoshikawa, Takaki, Miyagi, Yohei, Morita, Satoshi, Yamamoto, Michio, Tanabe, Kazuaki, Nishikawa, Kazuhiro, Ito, Yuichi, Matsui, Takanori, Kimura, Yutaka, Yokose, Tomoyuki, Hiroshima, Yukihiko, Aoyama, Toru, Hayashi, Tsutomu, Ogata, Takashi, Cho, Haruhiko, Rino, Yasushi, Masuda, Munetaka, Tsuburaya, Akira, Sakamoto, Junichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392622/
https://www.ncbi.nlm.nih.gov/pubmed/32774771
http://dx.doi.org/10.18632/oncotarget.27658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392622/
https://www.ncbi.nlm.nih.gov/pubmed/32774771
http://dx.doi.org/10.18632/oncotarget.27658

Ejemplares similares